Results 31 to 40 of about 7,902 (191)

THREE DIFFERENT CHEMOMETRIC APPROACHES COUPLED WITH UV SPECTROSCOPY FOR ANALYSIS OF AMLODIPINE AND OLMESARTAN IN PRESENCE OF THEIR ACIDIC DEGRADATION PRODUCTS [PDF]

open access: yesAl-Azhar Journal of Pharmaceutical Sciences, 2022
Amlodipine and olmesartan are two different antihypertensive drugs used in combination in the management of mild to severe hypertension. Degradation of the drug is one of the fatal processes.
Amr Eissa   +3 more
doaj   +1 more source

Hemorrhagic Cystitis With Bladder Tamponade Associated With <i>Morganella morganii</i> in an Older Patient Without Recent Catheterization. [PDF]

open access: yesIJU Case Rep
ABSTRACT Introduction Morganella morganii is an uncommon cause of urinary tract infection, typically associated with catheterization or underlying diseases. Case Presentation I report a rare case of severe hemorrhagic cystitis with massive intravesical clot retention in a 90‐year‐old woman without recent catheterization or diabetes mellitus ...
Kawaguchi Y.
europepmc   +2 more sources

PROTECTIVE ROLE OF TELMISARTAN, CANDESARTAN AND OLMESARTAN ON COLD RESTRAINT STRESS -INDUCED GASTRIC ULCER IN RATS: INFLUENCE OF PPAR Γ MRNA [PDF]

open access: yesAl-Azhar Journal of Pharmaceutical Sciences, 2012
Certain angiotensin receptor blockers (ARBs) possess peroxisome proliferators activator receptor gamma (PPAR-γ) activating potency that correlates with their degree of lipophilicity.
Mona Tawfik
doaj   +1 more source

Olmesartan Inhibits Angiotensin II–Induced Migration of Vascular Smooth Muscle Cells Through Src and Mitogen-Activated Protein Kinase Pathways

open access: yesJournal of Pharmacological Sciences, 2010
Clinical studies have shown that angiotensin-receptor blockers (ARBs) reduce the risk of cardiovascular diseases in hypertensive patients. It is assumed that the reduction of the risk by ARBs may be attributed in part to the inhibition of angiotensin II (
Yoji Kyotani   +6 more
doaj   +1 more source

Comparative effect of olmesartan and candesartan on lipid metabolism and renal function in patients with hypertension: a retrospective observational study

open access: yesCardiovascular Diabetology, 2011
Background Angiotensin II receptor blockers (ARBs), including olmesartan and candesartan, are widely used antihypertensive agents. Many clinical studies have demonstrated that ARBs have organ-protecting effects, e.g., cardioprotection, vasculoprotection ...
Nakayama Tomohiro   +4 more
doaj   +1 more source

The Preferential Inhibitory Effect of Olmesartan, a New Angiotensin II Type 1 Antagonist, on Sympathetic Nerve Terminals in Isolated Canine Splenic Artery

open access: yesJournal of Pharmacological Sciences, 2003
Effects of olmesartan (RNH-6270: (5-methyl-2-oxo-1,3-dioxolen-4-yl)methoxy-4-(1-hydroxy-1-methylethyl)-2-propyl{4-[2-(tetrazol-5-yl)-phenyl]phenyl}methylimidazol-5-carboxylase, an active form of olmesartan medoxomil (CS-866)) was investigated in isolated,
Shigetoshi Chiba, Xiao-Ping Yang
doaj   +1 more source

Olmesartan in Management of Proteinuria [PDF]

open access: yesJournal of Clinical and Diagnostic Research, 2018
Proteinuria is a marker and predictor of cardiovascular morbidity and mortality. Blockade of angiotensin receptor might result in reduction in proteinuria.
Satyanarayan Routray   +5 more
doaj   +1 more source

Combination Therapy with Olmesartan and Amlodipine in the Treatment of Hypertension

open access: yesPharmaceuticals, 2009
Background: Combination therapy with antihypertensive agents utilises different mechanisms of action and may be responsible for a more effective decrease in blood pressure.
Menco G. Niemeijer, Ton J. Cleophas
doaj   +1 more source

Olmesartan-Associated Enteropathy: An Unexpected Cause of Chronic Diarrhoea [PDF]

open access: yes, 2019
Olmesartan-associated enteropathy is a rare cause of severe enteropathy that should be considered in the differential diagnosis of patients with unexplained chronic diarrhoea.
Mónica Martins Teixeira   +13 more
core   +1 more source

Olmesartan-induced enteropathy

open access: yesBMJ Case Reports, 2018
Olmesartan-induced enteropathy (OIE) typically presents with a constellation of signs and symptoms including chronic diarrhoea, weight loss and villous atrophy on biopsy. We describe a 68-year-old Caucasian woman with a history of hypothyroidism and hypertension who presented to our hospital with recurrent episodes of acute intermittent diarrhoea ...
Nirmal K Onteddu   +3 more
openaire   +3 more sources

Home - About - Disclaimer - Privacy